384.00
+1.00
+(0.26%)
As of 1:51:19 PM GMT+1. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 11 | 8 | 18 | 16 |
Avg. Estimate | 16.53B | 15.45B | 64.88B | 65.87B |
Low Estimate | 15.69B | 14.96B | 61.67B | 62.38B |
High Estimate | 17.03B | 16.32B | 66.57B | 72.53B |
Year Ago Sales | 17.07B | 15.8B | 67.06B | 64.88B |
Sales Growth (year/est) | -3.14% | -2.20% | -3.24% | 1.52% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
CAT1.F | -- | -- | -- | -- |
S&P 500 | 9.34% | 11.29% | 14.06% | 13.55% |
Upgrades & Downgrades
Maintains | JP Morgan: Overweight to Overweight | 10/14/2024 |
Downgrade | Morgan Stanley: Equal-Weight to Underweight | 10/14/2024 |
Maintains | Citigroup: Buy to Buy | 10/9/2024 |
Maintains | Truist Securities: Buy to Buy | 10/9/2024 |
Maintains | B of A Securities: Buy to Buy | 9/30/2024 |
Maintains | Evercore ISI Group: In-Line to In-Line | 8/19/2024 |